OBJECTIVE To investigate effect of Urenalobataleaves extract on glucagon like peptide-1(GLP-1)serum level by inhibition of dipeptidyl peptidase-Ⅳ(DPP-Ⅳ)on diabetic rat. METHODS This study uses control group post test only with male spraque dawley rats.Diabetic rats was induced by High Fructose Diet(HFD)and single dose streptozotocin 25mg·kg-1 bw intra peritoneal.The rat was administrated orally with ethanolic extract of U.lobataleaves in dose of 250,500 and 1000mg·kg-1 for 4weeks.Blood sample were collected from the tail vein at 15 min after oral glucose administration and then DPP-Ⅳserum level and GLP-1were examined using a rat elisa kits of DPP-Ⅳ and GLP-1.The data was analyzed using ANOVA test continued with LSD test(P<0.05).RESULTS The oral administration of U.lobataleaves extract at dose of 250,500 and 1000mg·kg-1 bw were able to prolong GLP-1 bioavaibility approximately 5,2and 2.5-fold respectively compared to diabetic group(P<0.05),while the DPP-Ⅳ serum level was decreased by 60%,50% and 40%(P<0.05),respectively.In diabetic groups,DPP-Ⅳ serum level was increased more and less 4-fold compared to normal group(P<0.05)while the GLP level were decreased by 8-fold(P<0.05).CONCLUSION U.lobataleaves extract could prolong GLP-1 bioavaibility by reducing of DPP-Ⅳserum level.This effect may be related to active compounds that act as an DPP-Ⅳinhibitor in U.lobata extract. OBJECTIVE To investigate the effect of Urenalobataleaves extract on glucagon like peptide-1 (GLP-1) serum level by inhibition of dipeptidyl peptidase-IV (DPP-IV) on diabetic rat. METHODS This study uses control group post test only with male spraque dawley rats . Diabetic rats were induced by High Fructose Diet (HFD) and single dose streptozotocin 25 mg · kg -1 bw intra peritoneal. The rat was administrated orally with ethanolic extract of U.lobataleaves in dose of 250, 500 and 1000 mg · kg -1 for 4weeks. Blood samples were collected from the tail vein at 15 min after oral glucose administration and then DPP-IV serum level and GLP-1were examined using a rat elisa kits of DPP-IV and GLP-1. The data was analyzed using ANOVA test continued with LSD (P <0.05) .RESULTS The oral administration of U.lobataleaves extract at dose of 250,500 and 1000 mg · kg -1 bw were able to prolong GLP-1 bioavaibility approximately 5,2 and 2.5-fold respectively compared to diabetic group (P < 0.05), while the DPP-IV serum level was de DPP-IV serum level was increased more and less 4-fold compared to normal group (P <0.05) while the GLP level was decreased more than 4-fold compared to normal group (P <0.05) by 8-fold (P <0.05) .CONCLUSION U.lobataleaves extract could prolong GLP-1 bioavaibility by reducing of DPP-IV serum level. This effect may be related to active compounds that act as an DPP-IV inhibitor in U. lobata extract.